Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zhongxing Yangfan Bioengineering is a biotechnology company specializing in the development and manufacture of in vitro diagnostic (IVD) solutions, with a core focus on molecular diagnostics. Based in Shenzhen, China, the company provides a comprehensive portfolio of nucleic acid extraction reagents, automated extraction instruments, and PCR-based detection kits. Their clinical applications primarily cover infectious disease screening, including HPV genotyping, tuberculosis detection, and respiratory pathogen panels. The company operates under international quality standards such as ISO 13485 and serves a broad client base of hospitals and clinical laboratories. By integrating advanced molecular biology techniques with automated platforms, Zhongxing Yangfan aims to improve the efficiency and accuracy of clinical diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Zhongxing Yangfan Bioengineering.